Broadstone Net Lease Inc is a real estate investment trust (REIT) that focuses on acquiring and managing a diverse portfolio of net lease commercial properties
The company primarily invests in single-tenant, mission-critical properties that are leased to high-quality tenants across various industries. With a strategy centered on long-term, stable cash flows, Broadstone seeks to provide investors with a reliable source of income through strategically selected properties that are often located in key markets, ensuring a robust platform for growth and value creation.
Companies Reporting Before The Bell • Gatos Silver (NYSEGATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
As of Dec. 11, 2023, five stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Real estate investment trusts (REITs) are often popular with income-oriented investors because receiving regular monthly or quarterly dividends is comforting to those who rely on such payments for ongoing household or other bills.
BMO Capital has decided to maintain its Outperform rating of Broadstone Net Lease (NYSEBNL) and lower its price target from $24.00 to $19.00. Shares of Broadstone Net Lease are trading down 3.9% over the last 24 hours, at $15.77 per share.
From A to Z: All The REITs Hitting New 52-Week Lows This Week Real estate investment trusts (REITs) — and there are a lot of them — have gone from a New York Stock Exchange favorite to a stock to steer clear of.
Gainers Digital Media Solutions, Inc. (NYSEDMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results.
Gainers Timber Pharmaceuticals, Inc. (NYSETMBR) shares rose 63.8% to $0.1769. Timber Pharmaceuticals recently announced closing of $8.0 million public offering.
